908 Devices posts record Q3 revenue, narrows loss and lifts full‑year guidance

908 Devices reported third‑quarter 2026 revenue of $19.0 million, a 35% year‑over‑year increase, and a narrowed net loss of $4.6 million. Adjusted EBITDA loss was $1.7 million and cash balances stood at $99.1 million. The company raised its 2026 revenue outlook to $68.5 million‑$70.0 million and said the low end of the range reflects the quarter’s performance.

The higher guidance suggests stronger demand for the firm’s handheld chemical detection tools, which could support revenue growth in 2026. However, the pre‑market share decline of about 4.4% reflects investor concern over continued adjusted EBITDA losses and customer concentration.

  • 1Q3 2026 revenue was $19.0 million, up 35% from $14.0 million a year earlier.
  • 2Net loss from continuing operations narrowed to $4.6 million.
  • 3Adjusted EBITDA loss was $1.7 million.
  • 4Cash and cash equivalents were $99.1 million at quarter end.
  • 5Full‑year 2026 revenue guidance was raised to $68.5 million‑$70.0 million.
  • 6Adjusted EBITDA loss for 2026 is expected to be a mid‑single‑digit‑million dollar amount.

Sources